Format

Send to

Choose Destination
Am J Transplant. 2017 Sep;17(9):2481-2484. doi: 10.1111/ajt.14426.

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine.

Author information

1
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA.
PMID:
28846836
DOI:
10.1111/ajt.14426
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center